Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Bicycle Therapeutics Plc (BCYC)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bicycle Therapeutics Plc since year 2005.
Table 2 shows the detailed insider transactions of Bicycle Therapeutics Plc since 2005.
The reporting company's ticker symbol is BCYC. The reporting company's CIK number is 1761612.
The total value of stock buying since 2005 is $45,860,850.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-05-29||Cambridge Innovation Capital (jersey) Ltd (10% Owner)||Buy||314,286||14.00||4,400,004|
|2019-05-28||Aquila Investments Iv||Buy||364,286||14.00||5,100,004|
|2019-05-28||Harland Deborah (Director)||Buy||385,714||14.00||5,399,996|
|2019-05-28||Anstey Michael (Director)||Buy||314,286||14.00||4,400,004|
|2019-05-28||Sv Life Sciences Fund V Strategic Partners, L.p. (10% Owner)||Buy||385,715||14.00||5,400,010|
|2019-05-28||Bingham Kate (Director)||Buy||385,715||14.00||5,400,010|
|2019-05-28||Novartis Ag (10% Owner)||Buy||168,630||14.00||2,360,820|
|2019-05-27||Ng Carolyn (Director)||Buy||571,429||14.00||8,000,006|
Insider trading activities including stock purchases, stock sales, and option exercises of BCYC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bicycle Therapeutics Plc (symbol BCYC, CIK number 1761612) see the Securities and Exchange Commission (SEC) website.